Clinical Trial Detail

NCT ID NCT04249167
Title Cryoablation, Atezolizumab, and Nab-paclitaxel for the Treatment of Locally Advanced or Metastatic Triple Negative Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Mayo Clinic
Indications

triple-receptor negative breast cancer

Therapies

Atezolizumab + Nab-paclitaxel

Age Groups: senior adult

No variant requirements are available.